PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34712133-0	2021	Diminazen Aceturate Protects Pulmonary Ischemia-Reperfusion Injury via Inhibition of ADAM17-Mediated Angiotensin-Converting Enzyme 2 Shedding.	diminazene aceturate	0-19	ADAM metallopeptidase domain 17	Homo sapiens	85-91	
34712133-8	2021	Treatment with ACE2 protectant diminazen aceturate (DIZE) maintained higher ACE2 enzyme activity and reduced angiotensin II, angiotensin type 1 receptor, and ADAM17 levels in the lung tissue.	diminazene aceturate	31-50	ADAM metallopeptidase domain 17	Homo sapiens	158-164	
34712133-8	2021	Treatment with ACE2 protectant diminazen aceturate (DIZE) maintained higher ACE2 enzyme activity and reduced angiotensin II, angiotensin type 1 receptor, and ADAM17 levels in the lung tissue.	diminazene aceturate	52-56	ADAM metallopeptidase domain 17	Homo sapiens	158-164	
34712133-11	2021	We concluded that DIZE protects the lungs from IR injury via inhibition of ADAM17-mediated ACE2 shedding.	diminazene aceturate	18-22	ADAM metallopeptidase domain 17	Homo sapiens	75-81